SCHEMBL2956765

SCHEMBL2956765

Cc1ccc2ccc(Br)cc2c1C1C=Cc2ccccc21

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.32
CYP2A6 P11509 2/20 0.32
CYP1A2 P05177 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969251 0.91 SIRT2 (0.36) CYP2A6CYP1A2
SCHEMBL8601261 0.84 CYP1A2 (0.42) CYP2A6CYP1A2TSHR
SCHEMBL2966546 0.82 CYP2A6 (0.33) TYMSCYP2A6CYP1A2
SCHEMBL2970909 0.80 CYP2A6 (0.39) CYP2A6CYP1A2
SCHEMBL2969185 0.80 CYP2A6 (0.31) CYP2A6CYP1A2
SCHEMBL2965051 0.80 CYP1A2 (0.32) CYP1A2TSHR
SCHEMBL2970663 0.80 CYP1A2 (0.31) CYP1A2
SCHEMBL2969291 0.78 CYP2A6 (0.33) CYP2A6CYP1A2
SCHEMBL2973642 0.78 CYP2A6 (0.35) CYP2A6CYP1A2
SCHEMBL2962881 0.78 HTR6 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 TYMS 1479/4885CYP2A6 2465/4885CYP1A2 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.